MICHAELA MURPHY: Open Payments
NPI 1972124956 · THE COLONY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 20 payments from 13 companies in 2025. Trend: 2023 $344 · 2024 $413 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $76 |
| Lilly USA, LLC | 3 | $50 |
| PFIZER INC. | 2 | $43 |
| Dexcom, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $38 |
| Corcept Therapeutics | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Ozempic, PREVNAR 20, Dexcom G6 Transmitter, JARDIANCE, Korlym, MOUNJARO, Kerendia, TWIIST.
Industry payments across TX — which companies pay providers there.
